|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
Genmab A/S |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
Eton Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
BridgeBio Pharma, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
Agios Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
Sio Gene Therapies Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
Orchard Therapeutics plc |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
BioCryst Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
Kura Oncology, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
GRI Bio Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
Taysha Gene Therapies, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
Pixium Vision S.A. |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
Jasper Therapeutics, Inc |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
Novozymes A/S |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
BioSenic SA |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
Treace Medical Concepts, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 02 Feb 2024
|
Related companies:
NexImmune, Inc. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 02 Feb 2024
|
Related companies:
RemeGen Co., Ltd. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 02 Feb 2024
|
Related companies:
Mallinckrodt plc |
|